A simple, sensitive high-performance liquid chromatography -ultraviolet method for the quantification of concentration and steady-state pharmacokinetics of itraconazole and hydroxyitraconazole
暂无分享,去创建一个
H. Tagawa | M. Miura | H. Kagaya | M. Nara | N. Fujishima | H. Saitoh | N. Takahashi | K. Sawada | Y. Kameoka
[1] Gang-yi Liu,et al. Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by liquid chromatography-isotope dilution tandem mass spectrometry method. , 2009, Biomedical chromatography : BMC.
[2] Jun Kato,et al. Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole , 2009, International journal of hematology.
[3] Kishore Kumar Hotha,et al. Development and validation of a highly sensitive and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of itraconazole and hydroxyitraconazole in human plasma: application to a bioequivalence study. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[4] J. Beijnen,et al. Effects of Cyclosporine A on Single-Dose Pharmacokinetics of Intravenous Itraconazole in Patients With Hematologic Malignancies , 2008, Therapeutic drug monitoring.
[5] A. Espinel-Ingroff,et al. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies. , 2008, The Journal of antimicrobial chemotherapy.
[6] R. Kauffman,et al. Single-Dose Pharmacokinetics of Intravenous Itraconazole and Hydroxypropyl-β-Cyclodextrin in Infants, Children, and Adolescents , 2007, Antimicrobial Agents and Chemotherapy.
[7] R. Kauffman,et al. Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents. , 2007, Antimicrobial agents and chemotherapy.
[8] Mikiko Shimizu,et al. Sensitive Determination of Itraconazole and Its Active Metabolite in Human Plasma by Column-switching High-performance Liquid Chromatography With Ultraviolet Detection , 2006, Therapeutic drug monitoring.
[9] Y. L. Loukas,et al. Development of a high-throughput method for the determination of itraconazole and its hydroxy metabolite in human plasma, employing automated liquid–liquid extraction based on 96-well format plates and LC/MS/MS , 2006, Analytical and bioanalytical chemistry.
[10] T. Ohkubo,et al. Determination of itraconazole in human plasma by high-performance liquid chromatography with solid-phase extraction , 2005, Annals of clinical biochemistry.
[11] W. L. Nelson,et al. ROLE OF ITRACONAZOLE METABOLITES IN CYP3A4 INHIBITION , 2004, Drug Metabolism and Disposition.
[12] Vinod P. Shah,et al. Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.
[13] M. Vogeser,et al. Determination of Itraconazole and Hydroxyitraconazole in Plasma by Use of Liquid Chromatography-Tandem Mass Spectrometry with On-line Solid-Phase Extraction , 2003, Clinical chemistry and laboratory medicine.
[14] J. van Gestel,et al. Pharmacology of itraconazole. , 2001, Drugs.
[15] A. Carrier,et al. Liquid chromatographic-mass spectrometric determination of itraconazole and its major metabolite, hydroxyitraconazole, in dog plasma. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[16] D. Stevens,et al. Itraconazole in Cyclodextrin Solution , 1999, Pharmacotherapy.
[17] G. Cheymol,et al. Optimisation of Itraconazole Therapy Using Target Drug Concentrations , 1998, Clinical pharmacokinetics.
[18] J. Barone,et al. Enhanced Bioavailability of Itraconazole in Hydroxypropylβ-Cyclodextrin Solution versus Capsules in Healthy Volunteers , 1998, Antimicrobial Agents and Chemotherapy.
[19] D. Hillaire‐buys,et al. Prevalidation statistical design to assess analytical methods. Example of a quick liquid chromatographic assay of itraconazole in serum. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[20] B. Gazzard,et al. Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis. , 1997, Journal of clinical pathology.
[21] M. Ghannoum,et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] K. Goa,et al. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections. , 1996, Drugs.
[23] Anosh Joseph,et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers , 1993, Antimicrobial Agents and Chemotherapy.
[24] J. Cutsem. The In‐vitro Antifungal Spectrum of Itraconazole , 1989 .
[25] R. Woestenborghs,et al. The Clinical Pharmacokinetics of Itraconazole: An Overview , 1989, Mycoses.